![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » GLAXO MAY HAVE SHIPPED FAULTY ANTIDEPRESSANTS
GLAXO MAY HAVE SHIPPED FAULTY ANTIDEPRESSANTS
GlaxoSmithKline PLC, the world's second-biggest drugmaker, recalled Paxil CR antidepressants last month because the pills may have lacked an active ingredient, and didn't warn patients.
Boston Globe (http://www.boston.com/business/globe/articles/2006/10/05/glaxo_may_have_shipped_faulty_antidepressants/)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct